Results 121 to 130 of about 40,339 (186)

Expressions of P-glycoprotein, survivin and CD147 molecules on multidrug resistance leukemic cell line K562/Adr

Journal of Associated Medical Sciences, 2015
Introduction: Leukemia is a hematologic malignant disease. To date, chemotherapy is the most effective method for leukemia treatment. However, multidrug resistance (MDR) is a major obstacle of leukemia treatment failure.
Aoranit Somno, Songyot Anuchpreeda, Sawitree Chiampanichayakul   +2 more
doaj  

Liproxstatin‑1 induces cell cycle arrest, apoptosis, and caspase‑3/GSDME‑dependent secondary pyroptosis in K562 cells. [PDF]

Int J Oncol, 2022
Dong HQ, Liang SJ, Xu YL, Dai Y, Sun N, Deng DH, Cheng P.   +6 more
europepmc   +1 more source

Connexin 43-modified bone marrow stromal cells reverse the imatinib resistance of K562 cells via Ca 2+ -dependent gap junction intercellular communication. [PDF]

Chin Med J (Engl), 2023
Li X, Xiao Y, Wang X, Huang R, Wang R, Deng Y, Rao J, Gao Q, Yang S, Zhang X.   +9 more
europepmc   +1 more source

Potential Cytoprotective and Regulatory Effects of Ergothioneine on Gene Expression of Proteins Involved in Erythroid Adaptation Mechanisms and Redox Pathways in K562 Cells. [PDF]

Genes (Basel), 2022
Bernardo VS, Torres FF, de Paula CP, da Silva JPMO, de Almeida EA, da Cunha AF, da Silva DGH.   +6 more
europepmc   +1 more source

The Effects of Royal Jelly on In-Vitro Cytotoxicity of K562 Cells and Peripheral Blood Mononuclear Cells

Armaghane Danesh Bimonthly Journal, 2014
Background & aim: Royal jelly, secreted by worker bees, has different biological activities on cells and tissues. The aim of this study was to evaluate the effects of royal jelly on peripheral blood mononuclear cells and on the tumor category of K562 ...
SE Hosseini, N Delerezh, N Afzal Ahangaran   +2 more
doaj  

Inhibition of c-MYC-miRNA 19 Pathway Sensitized CML K562 Cells to Etoposide via NHE1 Upregulation. [PDF]

Oxid Med Cell Longev, 2022
Cao S, Xiong Q, Ding B, Wang X, Wei F, Sun Q, Yang F, Luo J, Chang G, Li S, Wang J.   +10 more
europepmc   +1 more source

Gene Expression Landscape of Chronic Myeloid Leukemia K562 Cells Overexpressing the Tumor Suppressor Gene PTPRG. [PDF]

Int J Mol Sci, 2022
Lombardi G, Latorre RV, Mosca A, Calvanese D, Tomasello L, Boni C, Ferracin M, Negrini M, Dewik NA, Yassin M, Ismail MA, Carpentieri B, Sorio C, Lecca P.   +13 more
europepmc   +1 more source

Sirolimus modulates the erythroid differentiation of K562 cells by upregulating SHP1. [PDF]

Ann Hematol
Yang Y, Tang Z, Hu Q, Yang C, Chen M, Jing H, Han B.   +6 more
europepmc   +1 more source

Retraction Note: Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs) induce apoptosis in K562 cells. [PDF]

BMC Cancer
Marfe G, Di Stefano C, Silvestri R, Abruzzese E, Catalano G, Di Renzo L, Filomeni G, Giorda E, Regina G, Morgante E, Ciriolo MR, Russo MA, Amadori S, Sinibaldi-Salimei P.   +13 more
europepmc   +1 more source

A Central Contribution of TG2 Activity to the Antiproliferative and Pro-Apoptotic Effects of Caffeic Acid in K562 Cells of Human Chronic Myeloid Leukemia. [PDF]

Int J Mol Sci, 2022
Feriotto G, Tagliati F, Brunello A, Beninati S, Tabolacci C, Mischiati C.   +5 more
europepmc   +1 more source